Smith & Nephew (SN.)

Sector:

Health Care

Index:

FTSE 100

961.00p
   
  • Change Today:
    -137.00p
  • 52 Week High: 1,208.50p
  • 52 Week Low: 923.40p
  • Currency: UK Pounds
  • Shares Issued: 874.37m
  • Volume: 11,229,723
  • Market Cap: £8,403m
  • RiskGrade: 173

Smith and Nephew Overview

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. It is focused on the repair, regeneration and replacement of soft and hard tissue. It operates through three segments: Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that helps surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue.

1 Day Chart (31-10-2024)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Smith and Nephew Financials

Latest F'cast
Div Yield 3.0% 0.0%
Div Cover 2.2 2.5
Op Mrgn 7.7% 15.9%
ROCE 9.1%  
Latest F'cast
P/E 14.9 15.4
PEG 12.2 n/a
Pr/Revenue 1.9 1.6
Pr/Book 2.1  
Latest F'cast
Revenue 6.4% -18.7%
PBT 23.4% 147.8%
EPS 1.2% -14.2%
DPS n/a -40.4%

Smith and Nephew Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 5,138.00 743.00 102.20¢ 23.1 23.1 +1% 37.50¢ 1.6%
31-Dec-20 4,560.00 246.00 64.60¢ 30.2 n/a -37% 37.50¢ 1.9%
31-Dec-21 5,212.00 586.00 80.90¢ 20.6 0.8 +25% 37.50¢ 2.2%
31-Dec-22 5,215.00 235.00 81.80¢ 17.5 17.5 +1% 37.50¢ 2.6%
31-Dec-23 5,549.00 290.00 82.80¢ 16.8 16.8 +1% 37.50¢ 2.7%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Smith and Nephew Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 5,820.51 927.16 71.00p 13.5 n/a -14% 28.81p 0.0%
31-Dec-25 6,137.42 1,095.33 84.91p 11.3 0.6 +20% 32.68p 0.0%
31-Dec-26 6,451.30 1,199.60 89.94p 10.7 1.8 +6% 36.11p 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Smith and Nephew Company Announcements

Smith+Nephew Third Quarter 2024 Trading Report 31-Oct-2024 07:00 RNS
Sterling Amount of Dividend 24-Oct-2024 07:00 RNS
Notice of Results 16-Oct-2024 07:00 RNS

Smith and Nephew ShareCast News

London close: Stocks down on corporate earnings,... 31-Oct-2024 ShareCast
Smith & Nephew cuts sales guidance on Chinese he... 31-Oct-2024 ShareCast
Sunday newspaper round-up: BP, Smith&Nephew, Tal... 13-Oct-2024 ShareCast

Smith and Nephew Top Newspaper Links

Festive cheer for Smith & Nephew as shares jump ... 26-Dec-2014 Daily Mail
Smith & Nephew shares jump 10pc on Stryker bid r... 26-Dec-2014 Telegraph
MARKET REPORT: Bid talk boosts Smith & Nephew 26-Nov-2014 Express & Star

Latest Smith and Nephew Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Smith and Nephew Market Data

Currency UK Pounds
Share Price 961.00p
Change Today -137.00p
% Change -12.48 %
52 Week High 1,208.50p
52 Week Low 923.40p
Volume 11,229,723
Shares Issued 874.37m
Market Cap £8,403m
RiskGrade 173

Smith and Nephew Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
85.15% below the market average85.15% below the market average85.15% below the market average85.15% below the market average85.15% below the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Price Trend
7.61% below the market average7.61% below the market average7.61% below the market average7.61% below the market average7.61% below the market average
35.14% above the sector average35.14% above the sector average35.14% above the sector average35.14% above the sector average35.14% above the sector average
Income
23.69% below the market average23.69% below the market average23.69% below the market average23.69% below the market average23.69% below the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average
Growth
35.25% below the market average35.25% below the market average35.25% below the market average35.25% below the market average35.25% below the market average
94.44% below the sector average94.44% below the sector average94.44% below the sector average94.44% below the sector average94.44% below the sector average

What The Brokers Say

Strong Buy 6
Buy 4
Neutral 6
Sell 0
Strong Sell 1
Total 17
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Smith and Nephew Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-24 28-Mar-24
Paid 08-Nov-24 22-May-24
Amount 14.40¢ 23.10¢

Trades for 31-Oct-2024

Time Volume / Share Price
16:39 9,806 @ 961.00p
16:37 194 @ 961.00p
16:37 10,000 @ 961.00p
16:35 600 @ 961.00p
16:35 400 @ 961.00p

Smith and Nephew Key Personnel

CEO Deepak Nath
CFO John Rogers

Top of Page